Halozyme Therapeutics | Ventes

Sales Changement Date
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 7.1M 296K 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amarin USD 74.71M 8.66M 2023-12
Amgen USD 8.2B 1.29B 2023-12
Baxter International USD 3.88B 177M 2023-12
Cytokinetics USD 1.67M 1.29M 2023-12
DBV Technologies USD 2.18M 68K 2023-09
Eli Lilly USD 8.77B 583.4M 2024-03
Halozyme Therapeutics USD 230.04M 14.01M 2023-12
Intra Cellular Therapies USD 132.1M 5.93M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
MannKind USD 58.47M 7.22M 2023-12
Pfizer USD 14.9B 651M 2024-03
United Therapeutics USD 677.7M 63M 2024-03



Halozyme Therapeutics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2024.